Larvol Delta - Neoadjuvant-Therapy-With-Firmonertinib-Combined-With-Anlotinib-and-PlatinumBased-Doublet-Chemotherapy-for-Resectable-EGFRMutated-NSCLC

carboplatin - Generic mfg.

Ivesa (firmonertinib) - Allist, ArriVent

Focus V (anlotinib) - Advenchen

http://clinicaltrials.gov/ct2/show/NCT07807722

Sep 9, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next